Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Chem Soc ; 130(39): 12953-60, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18767848

ABSTRACT

Siramesine (SRM) is a sigma-2 receptor agonist which has been recently shown to inhibit growth of cancer cells. Fluorescence spectroscopy experiments revealed two distinct binding sites for this drug in phospholipid membranes. More specifically, acidic phospholipids retain siramesine on the bilayer surface due to a high-affinity interaction, reaching saturation at an apparent 1:1 drug-acidic phospholipid stoichiometry, where after the drug penetrates into the hydrocarbon core of the membrane. This behavior was confirmed using Langmuir films. Of the anionic phospholipids, the highest affinity, comparable to the affinities for the binding of small molecule ligands to proteins, was measured for phosphatidic acid (PA, mole fraction of X(PA) = 0.2 in phosphatidylcholine vesicles), yielding a molecular partition coefficient of 240 +/- 80 x 10(6). An MD simulation on the siramesine:PA interaction was in agreement with the above data. Taking into account the key role of PA as a signaling molecule promoting cell growth our results suggest a new paradigm for the development of anticancer drugs, viz. design of small molecules specifically scavenging phospholipids involved in the signaling cascades controlling cell behavior.


Subject(s)
Indoles/chemistry , Phosphatidic Acids/chemistry , Phospholipids/chemistry , Spiro Compounds/chemistry , Calorimetry, Differential Scanning , Computer Simulation , Indoles/metabolism , Kinetics , Lipid Bilayers/chemistry , Liposomes/chemistry , Phosphatidic Acids/metabolism , Phospholipids/metabolism , Second Messenger Systems , Spectrometry, Fluorescence , Spiro Compounds/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...